Close
Achema

Drug Research

IFF Displays Innovative Pharmaceutical Solutions, Tailored to Address Current,...

As the pharmaceutical industry continues to evolve – introducing increasingly complex drugs, unique applications and new dosage forms – the Pharma Solutions division of IFF...

Moderna and Metagenomi Establish Collaboration to Develop Next-Generation In...

Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Metagenomi, Inc., a genetic medicines company with a versatile portfolio of next-generation...

University of Kent research identifies novel Covid-19 therapy

Researchers have identified a potential new treatment that suppresses the replication of SARS-CoV-2, the coronavirus that causes Covid-19. In order to multiply, all viruses, including coronaviruses,...

Pfizer and BioNTech Receive First U.S. FDA EUA of...

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years...

WuXi Biologics Launches a New GMP Commercial Drug Product...

WuXi Biologics, a global company with leading open-access biologics technology platforms, announced it has successfully launched the GMP operation of its new drug product facility...

Novavax and Serum Institute of India Receive Emergency Use...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the...

BioNTech Plans to Initiate the Construction of an mRNA...

BioNTech SE announced that the Company plans to initiate the construction of the first state-of-the-art manufacturing site for mRNA-based vaccines in the African Union in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read